What is CCEL stock price today?

CCEL (Cryo Cell International Inc) stock is trading at $3.71 as of the latest market data. Stock prices update in real-time during market hours (9:30 AM - 4:00 PM ET).

Is CCEL stock going up or down today?

CCEL stock price movements are influenced by market conditions, news, earnings reports, and investor sentiment. Check our live dashboard for real-time price changes and technical indicators.

Should I buy CCEL stock now?

The decision to buy CCEL depends on your investment strategy, risk tolerance, and financial goals. Our AI analysis evaluates fundamentals, valuation metrics, growth prospects, and market conditions to help inform your decision.

Is CCEL a buy, hold, or sell right now?

Our AI-powered analysis provides buy/hold/sell recommendations for CCEL based on multiple factors including valuation, growth metrics, technical indicators, and analyst consensus. Visit our dashboard for the latest recommendation.

Is CCEL stock overvalued or undervalued?

Use our DCF valuation calculator to determine if CCEL is overvalued or undervalued based on fundamental analysis and future cash flow projections.

What is CCEL's P/E ratio?

P/E ratio data for CCEL will be available after the company reports earnings. Visit our dashboard for the latest financial metrics.

What is CCEL's market cap?

CCEL (Cryo Cell International Inc) has a market capitalization of $0.03 billion, making it a small-cap stock.

What is CCEL's price to book ratio?

CCEL trades at a price-to-book (P/B) ratio of 9.72, which compares the stock price to the company's book value per share. A P/B below 1.0 may indicate undervaluation, while above 3.0 may suggest premium pricing.

Does CCEL pay dividends?

Yes, CCEL pays dividends with a current yield of 0.11%. Dividend payments provide income for investors in addition to potential stock price appreciation.

What is CCEL's dividend yield?

CCEL's dividend yield is 0.11%, calculated as annual dividends divided by the current stock price. This represents the annual return from dividends alone.

Is CCEL stock a good long-term investment?

CCEL's long-term investment potential depends on sustainable competitive advantages, revenue growth, profitability, management quality, and industry dynamics. Our AI analysis evaluates these factors to assess long-term prospects.

What is CCEL's revenue growth rate?

CCEL has shown revenue growth of -0.0% over recent periods. Consistent revenue growth is a key indicator of business health and competitive positioning.

CCEL is currently operating at a loss. Some companies prioritize growth over profitability in early stages. Review our financial analysis for detailed insights.

What are the risks of investing in CCEL?

Key risks for CCEL include market volatility, competitive pressures, regulatory changes, economic conditions, execution risks, and company-specific factors. Our AI analysis identifies material risks and their potential impact on valuation.

How does CCEL compare to its competitors?

Compare CCEL to industry peers on our dashboard using metrics like P/E ratio, revenue growth, profit margins, market share, and valuation multiples. Competitive analysis helps contextualize CCEL's performance and positioning.

What is CCEL's stock price target for 2026?

Our AI model provides price targets for CCEL based on fundamental analysis: Bull case $4.82 (+30%), Base case $4.27 (+15%), Bear case $3.34 (-10%). Visit our prediction page for detailed forecasts.

What do analysts say about CCEL?

Wall Street analysts provide ratings (buy/hold/sell) and price targets for CCEL. Our dashboard aggregates analyst consensus, target prices, and recent upgrades/downgrades to help you understand professional sentiment.

When is CCEL's next earnings report?

CCEL reports earnings quarterly. Check our dashboard for the upcoming earnings date, analyst estimates for revenue and EPS, and historical earnings performance. Earnings reports often drive significant stock price movements.

CCEL - Cryo Cell International Inc

NYSE * Health Care * Health Care Providers & Services

$3.71

+$0.04 (+1.09%)

About Cryo Cell International Inc

Cryo-Cell International, Inc. engages in cord blood and cord tissue cryopreservation services in the United States. The company offers cellular processing and cryogenic storage for family use, primarily for collection and preservation of umbilical cord blood, and tissue stem cells; and cellular processing and cryogenic storage of umbilical cord blood stem cells for public use. It is also involved in the manufacturing of PrepaCyte CB processing system units for processing umbilical cord blood stem cells. In addition, the company provides cold storage services to third-party pharmaceutical companies and medical institutions. It markets its cord blood stem cell preservation services directly to expectant parents, as well as by distributing information through obstetricians, pediatricians, childbirth educators, certified nurse-midwives, and other related healthcare professionals. The company was incorporated in 1989 and is headquartered in Oldsmar, Florida.

CCEL Key Statistics

Market Cap

$29.56M

P/B Ratio

9.72

EPS

$-0.30

Dividend Yield

0.11%

Revenue Growth

-0.0%

Profit Margin

-0.1%

Employees

How CCEL Compares to Peers

CCEL is the smallest among peers, which may offer higher growth potential

P/E Rank

N/A

of 1

Margin Rank

of 2

Growth Rank

of 2

Size Rank

of 2

Company	Market Cap	P/E	Growth	Margin	Compare
CCEL(This stock)	$29.56M	N/A	-0%	-0.1%	-
AMZNAmazon Com	$2.67T	34.6	0%	0.1%	vs AMZN

Cryo Cell International Inc Company Information

Headquarters: Florida; U.S.A
Website: www.cryo-cell.com
Sector: Health Care
Industry: Health Care Providers & Services

CCEL - Cryo Cell International Inc

About Cryo Cell International Inc

CCEL Key Statistics

How CCEL Compares to Peers

Cryo Cell International Inc Company Information

CCEL Lician Score

CCEL Financial Snowflake

Upcoming Events for CCEL